{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:37:43Z","timestamp":1788871063945,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ejphar.2009.04.068","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T04:25:38Z","timestamp":1242275138000},"page":"201-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice"],"prefix":"10.1016","volume":"615","author":[{"given":"Yoshihiko","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luvsandorj","family":"Oyunzul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Yuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Sasamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.04.068_bib1","first-page":"801","article-title":"Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"Standardization Sub-committee of the International Continence Society. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Committee Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2009.04.068_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(03)00622-7","article-title":"Antimuscarinics for the treatment of overactive bladder","volume":"3","author":"Andersson","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0022-5347(17)38030-8","article-title":"Muscarinic receptor stimulation of phosphoinositide hydrolysis in the human isolated urinary bladder","volume":"146","author":"Andersson","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0022-3565(25)24446-9","article-title":"In vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency","volume":"272","author":"Beauchamp","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.04.068_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/A:1022844517200","article-title":"Use of M1\u2013M5 muscarinic receptor knockout mice as novel tools to lineate the physiological roles of the muscarinic cholinergic system","volume":"28","author":"Bymaster","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2009.04.068_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(93)90027-B","article-title":"Muscarinic receptor: characterization, coupling and function","volume":"58","author":"Caulfield","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2009.04.068_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of overactive bladder","volume":"55","author":"Chapple","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2009.04.068_bib9","doi-asserted-by":"crossref","first-page":"C1063","DOI":"10.1152\/ajpcell.1991.261.6.C1063","article-title":"Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems","volume":"261","author":"Dai","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.bjp.0706723","article-title":"Involvement of Rho kinase and protein kinase C in carbachol-induced calcium sensitization in \u03b2-escin skinned rat and guinea-pig bladders","volume":"148","author":"Durlu-Kandilci","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0773.1996.tb00181.x","article-title":"Selective muscarinic receptor agonists and antagonists","volume":"78","author":"Eglen","year":"1996","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0165-6147(94)90047-7","article-title":"Muscarinic acetylcholine receptors in smooth muscle","volume":"15","author":"Eglen","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2009.04.068_bib13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(25)23162-7","article-title":"Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain","volume":"255","author":"Ehlert","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.04.068_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/mol.66.2.260","article-title":"Cholinergic stimulation of salivary secretion studies with M1 and M3 muscarinic receptor single- and double-knockout mice","volume":"66","author":"Gautam","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0022-5347(01)67039-3","article-title":"Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells","volume":"154","author":"Harriss","year":"1995","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","article-title":"Muscarinic receptor subtypes","volume":"30","author":"Hulme","year":"1990","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00210-002-0554-x","article-title":"M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland","volume":"366","author":"Ikeda","year":"2002","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1476-5381.2009.00113.x","article-title":"Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1\u2013M5 single knockout mice","volume":"156","author":"Ito","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/sj.bjp.0704241","article-title":"Dependency of detrusor contractions on calcium sensitization and calcium entry through LOE-908-sensitive channels","volume":"134","author":"Jezior","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-2999(03)01642-X","article-title":"Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4","volume":"468","author":"Karasawa","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrd1110","article-title":"Predicting therapeutic value in the lead optimization phase of drug discovery","volume":"2","author":"Kenakin","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2009.04.068_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.lfs.2003.07.019","article-title":"Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells","volume":"74","author":"Kobayashi","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.04.068_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0922-4106(90)90052-Y","article-title":"Muscarinic M3 receptors are coupled to two signal transduction pathways in rat submandibular cells","volume":"188","author":"Laniyonu","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.04.068_bib25","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1073\/pnas.97.17.9579","article-title":"Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype","volume":"97","author":"Matsui","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2009.04.068_bib26","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1523\/JNEUROSCI.22-24-10627.2002","article-title":"Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable","volume":"22","author":"Matsui","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2009.04.068_bib27","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.lfs.2004.05.034","article-title":"Functional analysis of muscarinic acetylcholine receptors using knockout mice","volume":"75","author":"Matsui","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.04.068_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1113\/jphysiol.2004.064626","article-title":"M3 muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice","volume":"558","author":"Nakamura","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine\u2014a new bladder-selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib30","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0024-3205(98)00495-0","article-title":"Ex vivo occupancy by tamsulosin of a1-adrenoceptors in rat tissues in relation to the plasma concentration","volume":"63","author":"Ohkura","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.04.068_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejphar.2004.03.044","article-title":"In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats","volume":"492","author":"Ohtake","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1248\/bpb.30.54","article-title":"Pharmacologial characterization of a new antimuscarinic agent, solifenacin succcinate, in comparison with other antimuscarinic agents","volume":"30","author":"Ohtake","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2009.04.068_bib33","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/01.ju.0000138472.16876.8d","article-title":"Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder","volume":"172","author":"Oki","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjp.0706184","article-title":"Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice","volume":"145","author":"Oki","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib35","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1248\/bpb.29.1397","article-title":"Comparative evaluation of exocrine muscarinc receptor binding characteristics and inhibition of salivation of solifenacin in mice","volume":"29","author":"Oki","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2009.04.068_bib36","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1248\/bpb.30.2324","article-title":"Effects of intravenously and orally administered solifenacin succinate (YM905) on carbachol-induced intravesical pressure elevation and salivary secretion in mice","volume":"30","author":"Okutsu","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2009.04.068_bib37","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/jpet.103.063735","article-title":"Signal transduction underlying carbachol-induced contraction of human urinary bladder","volume":"309","author":"Schneider","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.04.068_bib38","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1016\/j.amjmed.2005.12.011","article-title":"Using anticholinergic agents to treat overactive bladder: the issue of treatment tolerability","volume":"119","author":"Staskin","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2009.04.068_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1476-5381.1995.tb14928.x","article-title":"The receptor occupation and plasma concentration of NKY-722, a water-soluble dihydropyridine-type calcium antagonist, in spontaneously hypertensive rats","volume":"114","author":"Uchida","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/10606820308262","article-title":"M1\u2013M5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system","volume":"9","author":"Wess","year":"2003","journal-title":"Recept. Channels."},{"key":"10.1016\/j.ejphar.2009.04.068_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2009.04.068_bib42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bjp.0705109","article-title":"Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle","volume":"138","author":"Wibberley","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0022-3565(25)32274-3","article-title":"Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydomine treatment","volume":"215","author":"Yamada","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.04.068_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0022-3565(24)29676-2","article-title":"In vivo demonstration of a1A-adrenoceptor subtype selectivity of KMD-3213 in rat tissues","volume":"296","author":"Yamada","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.04.068_bib45","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0024-3205(01)01541-7","article-title":"In vivo receptor binding of benidipine and amlodipine in mesenteric arteries and other tissues of spontaneously hypertensive rats","volume":"70","author":"Yamada","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.04.068_bib46","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.bjp.0705371","article-title":"In vitro and ex vivo effects of a selective nociceptin\/orphanin FQ (N\/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N\/OFQ and [35S]GTPgS in rat brain and spinal cord","volume":"139","author":"Yamada","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.068_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs Aging"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990900449X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990900449X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:09:47Z","timestamp":1757974187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990900449X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":47,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S001429990900449X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.04.068","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.04.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}